Institut für Humangenetik
Refine
Has Fulltext
- yes (135)
Is part of the Bibliography
- yes (135)
Year of publication
Document Type
- Journal article (122)
- Doctoral Thesis (13)
Language
- English (135) (remove)
Keywords
- DNA methylation (9)
- BRCA1 (5)
- DNA repair (5)
- breast cancer (5)
- heterochromatin (5)
- mutations (5)
- ovarian cancer (5)
- Anura (4)
- Fanconi anemia (4)
- Fanconi-Anämie (4)
- consortium (4)
- epigenetics (4)
- gene (4)
- genetics (4)
- 5-Methylcytosine (3)
- DNS-Reparatur (3)
- Epigenetik (3)
- Genmutation (3)
- Medizin (3)
- Methylierung (3)
- genetic modifiers (3)
- genome-wide association (3)
- immunofluorescence (3)
- investigators (3)
- methylation (3)
- sperm (3)
- susceptibility loci (3)
- zebrafish (3)
- 2B (2)
- ADHD (2)
- B chromosomes (2)
- BRCA2 (2)
- Candida albicans (2)
- DNA (2)
- Epigenetics (2)
- FISH (2)
- FSHD (2)
- Fabry disease (2)
- Fabry genotype (2)
- Fabry phenotype (2)
- Fanconi Anämie (2)
- HPP (2)
- Makuladegeneration (2)
- Netzhaut (2)
- RPE (2)
- SLX4 (2)
- STR profile (2)
- Spermium (2)
- TNAP (2)
- VMD2 (2)
- bisulfite pyrosequencing (2)
- blood (2)
- cancer (2)
- common variants (2)
- copy number variation (2)
- diagnosis (2)
- disease genetics (2)
- duchenne muscular dystrophy (2)
- exome sequencing (2)
- extracellular matrix (2)
- fetal programming (2)
- fibrosis (2)
- genetic diagnostics (2)
- genome (2)
- genomic imprinting (2)
- gestational diabetes mellitus (2)
- gridle muscular-dystrophy (2)
- hearing impairment (2)
- hearing loss (2)
- hepatic stellate cell (2)
- hereditary breast and ovarian cancer (2)
- hypophosphatasia (2)
- immunodeficiency (2)
- intellectual disability (2)
- liver (2)
- microcephaly (2)
- mineralization (2)
- modifiers (2)
- mutation (2)
- myofibrillar myopathy (2)
- myofibroblast (2)
- myopathy (2)
- nervous system (2)
- next generation sequencing (2)
- next generation sequencing (NGS) (2)
- protein (2)
- sensory neuropathy (2)
- sex chromosomes (2)
- single-nucleotide polymorphisms (2)
- somatic mosaicism (2)
- spectral karyotyping (2)
- sperm DNA methylation (2)
- survival (2)
- variants (2)
- whole exome sequencing (2)
- (classical and atypical) Werner syndrome (1)
- 3D modeling (1)
- 3R (1)
- 5-methylcytosine (1)
- A chromosomes (1)
- AFLP (1)
- AKT-signaling (1)
- ALPL (1)
- AMD (1)
- ART outcome (1)
- ATM gene (1)
- Age-related macular degeneration (1)
- Allophrynidae (1)
- Alzheimer's disease (1)
- Alzheimerkrankheit (1)
- Anticoagulants (1)
- Asisted Reproduction (1)
- Aspergillus fumigatus (1)
- Autism (1)
- Autism spectrum disorders (1)
- Autismus (1)
- B4GALT7 gene (1)
- BMD (1)
- BRCA1/2 (1)
- BRIP1 gene (1)
- Best Disease (1)
- Best-Krankheit (1)
- Bioinformatics (1)
- Blasentumor (1)
- BrdU replication banding pattern (1)
- BrdU/dT replication banding (1)
- Brustkrebs (1)
- CAGSSS (1)
- CDC14A (1)
- CIN (1)
- CLRN2 (1)
- COVID-19 (1)
- CRISPR-Cas Systems (1)
- CRISPR/Cas9 (1)
- Centrolenidae (1)
- Charcot-Marie-Tooth neuropathy 1A (1)
- Checkpoints (1)
- Chromosomal instability (1)
- Chromosomenbruch (1)
- Coagulation factor IX (1)
- Coexpression (1)
- Cognitive control (1)
- Copy number variation (1)
- Cortex (1)
- Coumarin (1)
- Cranial sutures (1)
- D4Z4 partial deletion (1)
- DFNB32 (1)
- DFNB68 (1)
- DLX5/6 (1)
- DM2 (1)
- DNA Methylation (1)
- DNA Reparatur (1)
- DNA damage (1)
- DNA double-strand break (1)
- DNA methylation dynamics (1)
- DNA methyltransferase gene (1)
- DNA repair defect (1)
- DNA sequencing (1)
- DNA-Instabilitätssyndrom (1)
- DNA-Methylation (1)
- DNA-Quervernetzung (1)
- DNA-Repair (1)
- DNA-repair (1)
- DNA-repair genes (1)
- DNMT3B (1)
- DYNC1I1 (1)
- Damage (1)
- Deflazacort (1)
- Down syndrome (1)
- Duchenne dystrphy (1)
- Duchenne muscular dystrophy (1)
- ERCC1-XPF (1)
- ERCC4 (1)
- Embryos (1)
- Enhancer elements (1)
- Environment (1)
- Epigenotypus (1)
- Epimutation (1)
- Erbkrankheit (1)
- Evans syndrome (1)
- Extracellular matrix (1)
- FA (1)
- FANCA (1)
- FANCD2 (1)
- FANCP (1)
- Familial Beckwith-Wiedemann syndrome (1)
- Fanconi Anemia (1)
- Fanconi anaemia (1)
- Fanconi-anemia subtype (1)
- Fetal brain development (1)
- Fluorescence in situ hybridization (1)
- Fourthcorner analysis (1)
- Frontal cortex (1)
- GTL2 (1)
- Gecko (1)
- Gen (1)
- Gene-expression (1)
- Genes (1)
- Genetik (1)
- Genome (1)
- Genotype-phenotype association (1)
- Genotype–phenotype correlations (1)
- Hereditary breast cancer (1)
- High-throughput data (1)
- Hindbrain (1)
- Histologic grade (1)
- Holliday junction reolvass (1)
- Human prefrontal cortex (1)
- Hypophosphatasia (1)
- IARS2 (1)
- ICF2 (1)
- ICL (1)
- ICSI (1)
- IGF2-H19 (1)
- II citrullinemia (1)
- IMSI (1)
- Imprinting (1)
- Indian muntjac (1)
- Induced Pluripotent Stem Cells (1)
- Instability (1)
- KRAS (1)
- Keimzell- und Embryonalentwicklung (1)
- LGMDR5 (1)
- Limb development (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Long-term follow-up (1)
- MCPH1 (1)
- MEK/ERK-signaling (1)
- MFM (1)
- Male breast cancer (1)
- Malignant neoplasms (1)
- Mausmodell (1)
- Membranproteine (1)
- Methylome (1)
- Microarray analysis (1)
- Miyoshi myopathy (1)
- Molecular approaches (1)
- Molekularbiologie (1)
- Molekulargenetik (1)
- Morbus Best (1)
- Mosaizismus (1)
- Mucopolysaccharidosis IIIa (1)
- Multivariate analysis (1)
- Mutation (1)
- Mutationen (1)
- Mutationsanalyse (1)
- N170 (1)
- NEIL2 (1)
- Neanderthal (1)
- Neisseria meningitidis (1)
- Neuroepigenomics (1)
- Neurons (1)
- Next generation sequencing (1)
- OGG1 (1)
- Ordination methods (1)
- Ovarian (1)
- P100 (1)
- PCR (1)
- Pakistan (1)
- Parent-of-origin (1)
- Paternal age effect (1)
- Pathology (1)
- Patterns (1)
- Pigmentepithel (1)
- Pompe disease (1)
- RAD50-Defizienz (1)
- RAD51C (1)
- RAD52 (1)
- RLQ analysis (1)
- RNA-Seq analysis (1)
- RPE specific genes (1)
- Renal abnormalities (1)
- Repair (1)
- Reproduktionsmedizin (1)
- Retina (1)
- Reversion (1)
- Robertsonian translocation chromosomes (1)
- S1PR2 (1)
- SARS-CoV-2 (1)
- SH3 domain (1)
- SHFM (1)
- SKY analysis (1)
- SLC2A3 (1)
- SNP array (1)
- SNP-microarray (1)
- Schizophrenia (1)
- Selective attention (1)
- Self-renewal (1)
- Senile Makuladegeneration (1)
- Senile Makuladegeneration / Pigmentepithel / Genexpression (1)
- Skull (1)
- Somites (1)
- Spermien (1)
- Stability (1)
- Staphylococcus aureus (1)
- Suicidal behavior (1)
- Susceptibility (1)
- TMEM43 (1)
- TRIM32 (1)
- TYPE-2 (1)
- Terminal 4q deletion syndrome (1)
- Th17 (1)
- Transcription (1)
- Transcription regulation (1)
- Transcriptome (1)
- Transcriptomics (1)
- Transkription <Genetik> (1)
- Transkriptome (1)
- Tregs (1)
- UBZ (1)
- Urodela (1)
- Usher syndrome (1)
- VKORC1 (1)
- Vater (1)
- Visualization (1)
- Vitamin K epoxide reductase (1)
- Väterliches Alter (1)
- WDR62 mutation (1)
- Warfarin (1)
- Working memory (1)
- X chromosome (1)
- X-chromosomal inactivation (1)
- X. laevis-type karyotype (1)
- X. tropicalis-type karyotype (1)
- Xenopus (1)
- Xenopus laevis (1)
- Xenopus tropicalis (1)
- Y chromosome degeneration (1)
- ZBTB24 (1)
- ZBTB24 mutations (1)
- ZNF365 (1)
- ZW sex chromosomes (1)
- Zebrafish (1)
- Zellzyklus (1)
- abnormalities (1)
- adenoma (1)
- adrenal insufficiency (1)
- age at onset (1)
- age-related differentially methylated regions (ageDMRs) (1)
- aldehydes (1)
- alleles (1)
- allopolyploidy (1)
- alternative methods (1)
- alu elements (1)
- alzheimers disease (1)
- amphiphysin-2 BIN1 (1)
- amplicon sequencing (1)
- antidepressants (1)
- anxiety disorders (1)
- apoptosis (1)
- arrhythmogenic cardiomyopathy (1)
- asexual reproduction (1)
- assistierte Reproduktion (1)
- association (1)
- autism (1)
- autophagy (1)
- autopolyploidy (1)
- autosomal recessive hearing loss (1)
- autosomal recessive non-synstromic hearing loss (1)
- banding analyses (1)
- bcl-2 associated athanogene protein 3 (1)
- behavior (1)
- bestrophin (1)
- bioinformatics and computational biology (1)
- bleding disorders other than hemophilia (1)
- bone development (1)
- bone marrow failure syndrome (1)
- bovine (1)
- breast cancer predisposition genes (1)
- breast neoplasms (1)
- cadherins (1)
- cancer treatment (1)
- candida genome database (1)
- candidate genes (1)
- cardiogenetics (1)
- cardiomyopathy (1)
- case report (1)
- cataracts (1)
- cell (1)
- cell death (1)
- cell division (1)
- cell wall (1)
- centromeric instability (1)
- childhood cancer (1)
- children (1)
- chip-seq (1)
- chromosomal abnormality (1)
- chromosomal instability (1)
- chromosomale Instabilität (1)
- chromosome evolution (1)
- chromosome inversion (1)
- chromosome staining (1)
- chromsomal instability (1)
- classification (1)
- combined retinal dystrophy (1)
- comparative genomics (1)
- complex chromosome rearrangements (1)
- complex disorders (1)
- complex traits (1)
- computational prediction (1)
- congenital heart-deffects (1)
- congenital myopathy (1)
- connective tissue disorder (1)
- consanguinity (1)
- copy-number variation (1)
- craniosynostosis (1)
- cross-link repair (1)
- cytokinesis (1)
- cytotoxicity (1)
- damage (1)
- danazol (1)
- danio rerio (1)
- database (1)
- deafness (1)
- deep bisulfite sequencing (1)
- deficiency (1)
- deletion (1)
- design (1)
- developmental origins hypothesis (1)
- diagnostic delay (1)
- differentially methylated region (1)
- differentiation (1)
- diploidization (1)
- disease (1)
- disruption project (1)
- double trouble (1)
- duplication (1)
- duplication-deficiency (1)
- dysferlinopathy (1)
- dystrophin (1)
- eExons (1)
- early respiratory-failure (1)
- elective surgery (1)
- elements (1)
- embryos (1)
- endonuclease (1)
- epigenetic heterogeneity (1)
- epimutation (1)
- epithelial cells (1)
- establishment (1)
- euchromatin (1)
- evolutionary biology (1)
- evolutionary fixation (1)
- expansion (1)
- expression signature (1)
- extreme phenotypes (1)
- facial anomalies (1)
- facioscapulohumeral muscular dystrophy (1)
- familial breast cancer (1)
- families (1)
- fanconi anemia (1)
- fanconi-anemia (1)
- features (1)
- female (1)
- female Fabry patients (1)
- fetal brain development (1)
- fetal cord blood (1)
- fetal overnutrition (1)
- fibroblasts (1)
- filamin C (1)
- fine-scale mapping (1)
- fish (1)
- flies (1)
- frameshift (1)
- frontal cortex (1)
- functional analysis (1)
- functional modules (1)
- geckos (1)
- gene mutations (1)
- genetic causes of cancer (1)
- genetic counselling (1)
- genetic diagnosis (1)
- genetic heterogeneity (1)
- genetic interaction networks (1)
- genetic loci (1)
- genetic skeletal disorders (1)
- genetic susceptibility (1)
- genetic testing (1)
- genetic variants (1)
- genome sequencing (1)
- genome-wide association study (GWAS) (1)
- genome-wide linkage analysis (1)
- genomic analysis (1)
- genomic libraries (1)
- genomics (1)
- genotype-phenotype correlation (1)
- genotyping arrays (1)
- germline mutations (1)
- glycogenin 1 (1)
- gonads (1)
- granulomas (1)
- great dane (1)
- growth failure (1)
- growth hormone deficiency (1)
- gynogenesis (1)
- hand/foot malformation (1)
- haplogroups (1)
- haploinsufficiency (1)
- helicase BRIP1 (1)
- hematology (1)
- hemostasis and thrombosis (1)
- hereditary hearing loss (1)
- hereditary motor (1)
- hereditary motor and sensory neuropathy (1)
- heterogeneity (1)
- heteromorphic sex chromosomes (1)
- heterozygote (1)
- histological subtype (1)
- homoeologous chromosomes (1)
- hormone-related protein (1)
- host cells (1)
- human disease (1)
- human evolution (1)
- human medicine (1)
- humans (1)
- hybridogenesis (1)
- hypermethylated DNA (1)
- hypermethylation (1)
- illumina (1)
- immune thrombocytopenia (1)
- imprinting control region (1)
- in situ hybridization (1)
- in vitro model (1)
- incidence (1)
- induced pluripotent stem cells (1)
- infinium HumanOmni1-Quad (1)
- inflammation (1)
- inflammatory diseases (1)
- inherited myopathy (1)
- insulin treatment (1)
- intergenerational contraction (1)
- interolog (1)
- interstrand crosslink (1)
- intrachromosomal telomeric sequences (1)
- inversion (1)
- italian patients (1)
- karyotype evolution (1)
- kinase signaling (1)
- limb development (1)
- linked myotubular myopathy (1)
- live-born (1)
- lymphoma (1)
- lyso‐Gb3 (1)
- macrophages (1)
- macular degeneration (1)
- maintenance (1)
- male breast cancer (1)
- malformations (1)
- mammalian male germline (1)
- mammographic density (1)
- medical genetics (1)
- meiosis (1)
- meiotic chromosomes (1)
- meiotic ‘superring’ (1)
- membrane curvature (1)
- membrane repair (1)
- mental retardation (1)
- metabolic disease (1)
- metabolism (1)
- methylation array (1)
- mice (1)
- microdeletion syndrome (1)
- microdissection (1)
- midbody (1)
- middle aged (1)
- mineraliztion (1)
- missense mutations (1)
- mitotic chromosomes (1)
- mixed hearing loss (1)
- mixed mutation mechanisms (1)
- miyoshi myopathy (1)
- model (1)
- moderate-penetrance genes (1)
- molecular analysis (1)
- molecular cloning (1)
- monoubiquitination (1)
- monozygotic twins (1)
- mosaicism (1)
- mouse (1)
- mouse model (1)
- multiple diseases (1)
- multiple myeloma (1)
- muscle disease (1)
- muscle strength (1)
- muscular dystrophy (1)
- muscular-dystrophy (1)
- mutation analysis (1)
- natural variation (1)
- network analysis (1)
- network inference (1)
- networks (1)
- neurodevelopmental disorders / genetics (1)
- neuromuscular disease (1)
- neurotransmission (1)
- neutrophils (1)
- next-generation sequencing (1)
- next-generation-sequencing (1)
- nomenclature (1)
- non-mosaic (1)
- non-sense mediated mRNA decay (1)
- nonspecific alkaline-phosphae (1)
- oocytes (1)
- organ toxicity (1)
- overlapping syndrome (1)
- oxidative stress (1)
- p.R245H (1)
- p.S298P (1)
- painful (1)
- panel sequencing (1)
- panic disorder (1)
- paternal age (1)
- paternal age effect (1)
- paternal introgression (1)
- pathogen-host interaction (PHI) (1)
- pathogenicity (1)
- pathway (1)
- patient (1)
- penetrance (1)
- phalloidin stain (1)
- phenotype (1)
- phosphoproteome (1)
- platelet disorders (1)
- polymerase chain reaction (1)
- polymorphism (1)
- polyneuropathy (1)
- polyploidization (1)
- polyploidy (1)
- population (1)
- potential role (1)
- prednisone (1)
- premature aging (1)
- premutation (1)
- prevalence (1)
- promoter methylation (1)
- promotes (1)
- protein aggregation (1)
- protein interaction database (1)
- protein-protein interaction (1)
- proteins (1)
- proteomic signature (1)
- protocadherin gamma cluster (1)
- recessive inheritance (1)
- reciprocal translocation (1)
- recombination (1)
- recurrence (1)
- regulatory T cells (1)
- regulatory mutations (1)
- reproduction (1)
- requency (1)
- reversion (1)
- rhodamine–phalloidin stain (1)
- risk (1)
- sarcoglycanopathy (1)
- sarcotubular myopathy (1)
- screening (1)
- secondary cancer (1)
- segmental progeria (1)
- selection (1)
- sensorineural hearing loss (1)
- sequence alignment (1)
- sequence assembly tools (1)
- sex chromosome evolution (1)
- sex linked pigmentation pattern (1)
- sex ratio (1)
- sexual antagonistic genes (1)
- skeletal dysplasia (1)
- skeletal muscle (1)
- skeletal myopathy (1)
- sky kinases (1)
- species-specific epigenetic marks (1)
- spinal muscular atrophy (1)
- splicing (1)
- spondylodysplastic Ehlers-Danlos syndrome (1)
- steroids (1)
- stress fibers (1)
- structural genome variations (1)
- submicroscopic chromosome rearrangement (1)
- subtypes (1)
- suppression (1)
- susceptibility (1)
- susceptibility alleles (1)
- susceptibility gene (1)
- synaptonemal complex (1)
- systemic sclerosis (1)
- targeted gene panel (1)
- teeth (1)
- telomere length (1)
- telomeres (1)
- temperature (1)
- testes (1)
- testosterone (1)
- therapy (1)
- throat (1)
- tinnitus (1)
- tissue-specific enhancers (1)
- transcription deficiency (1)
- transcriptional regulation (1)
- transcriptome (1)
- transgenic animals (1)
- transporter gene SLC2A3 (1)
- transposable elements (1)
- treatment guidelines (1)
- triple-negative breast cancer (1)
- triplosufficiency (1)
- trisomy 21 (1)
- trisomy 22 (1)
- tumor subtypes (1)
- tumor-suppressor (1)
- twin study (1)
- type II esophageal achalasia (1)
- ubiquitin (1)
- vacuolar myopathy (1)
- ventilation (1)
- vertebrate (1)
- whole genome sequencing (1)
- whole genome sequencing (WGS) (1)
- whole-exome sequencing (1)
- α‐GalA 3D‐structure (1)
Institute
- Institut für Humangenetik (135)
- Theodor-Boveri-Institut für Biowissenschaften (27)
- Kinderklinik und Poliklinik (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (5)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (5)
- Medizinische Klinik und Poliklinik I (5)
- Neurologische Klinik und Poliklinik (4)
- Lehrstuhl für Orthopädie (3)
- Institut für Anatomie und Zellbiologie (2)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
Sonstige beteiligte Institutionen
- Comprehensive Hearing Center, Department of ORL, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Würzburg, Germany (1)
- DNA Analytics Core Facility, Biocenter, University of Würzburg, Würzburg, Germany (1)
- Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany (1)
- Maastricht University, Maastricht, the Netherlands (1)
Fanconi anemia (FA) is an autosomal recessive or X-chromosomal inherited disorder, which is not only phenotypically but also genotypically very heterogeneous. While its hallmark feature is progressive bone marrow failure, many yet not all patients suffer additionally from typical congenital malformations like radial ray defects and growth retardation. In young adulthood the cumulative risk for developing hematological or other malignancies is compared to the general population several hundred-fold increased. The underlying molecular defect is the deficiency of DNA interstrand crosslink (ICL) repair. ICLs are deleterious lesions, which interfere with crucial cellular processes like transcription and replication and thereby can lead to malignant transformation, premature senescence or cell death. To overcome this threat evolution developed a highly complex network of interacting DNA repair pathways, which is conserved completely only in vertebrates. The so called FA/BRCA DNA damage response pathway is able to recognize ICLs on stalled replication forks and promotes their repair through homologous recombination (HR). Today we know 15 FA genes (FANCA, -B, -C, -D1, -D2, -E, -F, -G, -I, -J, -L, -M, -N, -O and -P) whose products are involved in this pathway. Although more than 80% of FA patients carry biallelic mutations in either FANCA, FANCC or FANCG, there are still some who cannot be assigned to any of the known complementation groups. This work aimed to indentify the di¬sease causing mutations in a cohort of those unassigned patients. Initial screens of the candidate genes FAN1, MHF1 and MHF2 did not reveal any pathogenic alterations. Moreover, FAN1 could be excluded as FA candidate gene because patients carrying a homozygous microdeletion including the FAN1 locus did not show a phenotype comparable to FA patients. In the case of MHF1 and MHF2 the reason for the negative screening result is not clear. Mutation carriers might be rare or, regarding the diverse and also FA pathway independent protein functions, phenotypically not comparable to FA patients. Nevertheless, this study contri¬buted to the identification and characterization of the most recent members of the FA pathway - RAD51C (FANCO), SLX4 (FANCP) and XPF (FANCQ). FANCO is one of the RAD51 paralogs and is involved in crucial steps of HR. But since the only reported FA-O patient has so far not developed any hematological anomalies, FANCO is tentatively designated as gene underlying an FA-like disorder. In contrast, patients carrying biallelic mutations in FANCP do not only show hematological anomalies, but as well congenital malformations typical for FA. The distinct role of FANCP in the FA pathway could not be determined, but it is most likely the coordination of structure-specific nucleases during ICL excision. One of these nucleases is the heterodimer XPF/ERCC1. XPF is probably disease causing in the complementation group FA-Q and is the first FA gene, which was identified by Next Generation Sequencing (NGS). Extraordinarily is that mutations in this gene had previously been reported to cause two other disorders, xeroderma pigmentosum and segmental progeria. Despite some overlaps, it was shown that the divergent phenotypes could clearly be distinguished and are caused by distinct functional defects of XPF. Additionally, this work aimed to improve and accelerate the genotyping process of FA patients in general. Therefore, classical approaches should be complemented or fully replaced by approa¬ches using NGS. Massively parallel sequencing of the whole exome proved to be most appro¬priate and the establishment of an FA-specific analysis pipeline facilitated improved molecular diagnostics by combining complementation group assignment and mutation analysis in one step. Consequently two NGS studies revealed the pathogenic defect in several previously unassigned FA patients and thereby added another patient to one of the most recent subtypes, FA-P. In summary, this work contributed not only to further completion of the FA/BRCA DNA repair network by adding three novel genes, it also showed that classical molecular approaches for re¬search as well as for diagnostics could be replaced by NGS.
Fanconi anemia (FA) is a rare genomic instability syndrome. Disease-causing are biallelic mutations in any one of at least 15 genes encoding members of the FA/BRCA pathway of DNA-interstrand crosslink repair. Patients are diagnosed based upon phenotypical manifestationsand the diagnosis of FA is confirmed by the hypersensitivity of cells to DNA interstrand crosslinking agents. Customary molecular diagnostics has become increasingly cumbersome, time-consuming and expensive the more FA genes have been identified. We performed Whole Exome Sequencing (WES) in four FA patients in order to investigate the potential of this method for FA genotyping. In search of an optimal WES methodology we explored different enrichment and sequencing techniques. In each case we were able to identify the pathogenic mutations so that WES provided both, complementation group assignment and mutation detection in a single approach. The mutations included homozygous and heterozygous single base pair substitutions and a two-base-pair duplication in FANCJ, -D1, or - D2. Different WES strategies had no critical influence on the individual outcome. However, database errors and in particular pseudogenes impose obstacles that may prevent correct data perception and interpretation, and thus cause pitfalls. With these difficulties in mind, our results show that WES is a valuable tool for the molecular diagnosis of FA and a sufficiently safe technique, capable of engaging increasingly in competition with classical genetic approaches.
Biallelic mutations in MCPH1 cause primary microcephaly (MCPH) with the cellular phenotype of defective chromosome condensation. MCPH1 encodes a multifunctional protein that notably is involved in brain development, regulation of chromosome condensation, and DNA damage response. In the present studies, we detected that MCPH1 encodes several distinct transcripts, including two major forms: full-length MCPH1 (MCPH1-FL) and a second transcript lacking the six 39 exons (MCPH1De9–14). Both variants show comparable tissue-specific expression patterns, demonstrate nuclear localization that is mediated independently via separate NLS motifs, and are more abundant in certain fetal than adult organs. In addition, the expression of either isoform complements the chromosome condensation defect found in genetically MCPH1-deficient or MCPH1 siRNA-depleted cells, demonstrating a redundancy of both MCPH1 isoforms for the regulation of chromosome condensation. Strikingly however, both transcripts are regulated antagonistically during cell-cycle progression and there are functional differences between the isoforms with regard to the DNA damage response; MCPH1-FL localizes to phosphorylated H2AX repair foci following ionizing irradiation, while MCPH1De9–14 was evenly distributed in the nucleus. In summary, our results demonstrate here that MCPH1 encodes different isoforms that are differentially regulated at the transcript level and have different functions at the protein level.
Background: The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer. Methodology/Findings: To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to onecancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the twocancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy c-irradiated cells of two-cancer patients. Conclusions/Significance: Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
DNA methylation is an epigenetic modification that plays an important role in gene regulation. It can be influenced by stochastic events, environmental factors and developmental programs. However, little is known about the natural variation of genespecific methylation patterns. In this study, we performed quantitative methylation analyses of six differentially methylated imprinted genes (H19, MEG3, LIT1, NESP55, PEG3 and SNRPN), one hypermethylated pluripotency gene (OCT4) and one hypomethylated tumor suppressor gene (APC) in chorionic villus, fetal and adult cortex, and adult blood samples. Both average methylation level and range of methylation variation depended on the gene locus, tissue type and/or developmental stage. We found considerable variability of functionally important methylation patterns among unrelated healthy individuals and a trend toward more similar methylation levels in monozygotic twins than in dizygotic twins. Imprinted genes showed relatively little methylation changes associated with aging in individuals who are >25 years. The relative differences in methylation among neighboring CpGs in the generally hypomethylated APC promoter may not only reflect stochastic fluctuations but also depend on the tissue type. Our results are consistent with the view that most methylation variation may arise after fertilization, leading to epigenetic mosaicism.
Fanconi Anemia Core Complex Gene Promoters Harbor Conserved Transcription Regulatory Elements
(2011)
The Fanconi anemia (FA) gene family is a recent addition to the complex network of proteins that respond to and repair certain types of DNA damage in the human genome. Since little is known about the regulation of this novel group of genes at the DNA level, we characterized the promoters of the eight genes (FANCA, B, C, E, F, G, L and M) that compose the FA core complex. The promoters of these genes show the characteristic attributes of housekeeping genes, such as a high GC content and CpG islands, a lack of TATA boxes and a low conservation. The promoters functioned in a monodirectional way and were, in their most active regions, comparable in strength to the SV40 promoter in our reporter plasmids. They were also marked by a distinctive transcriptional start site (TSS). In the 59 region of each promoter, we identified a region that was able to negatively regulate the promoter activity in HeLa and HEK 293 cells in isolation. The central and 39 regions of the promoter sequences harbor binding sites for several common and rare transcription factors, including STAT, SMAD, E2F, AP1 and YY1, which indicates that there may be cross-connections to several established regulatory pathways. Electrophoretic mobility shift assays and siRNA experiments confirmed the shared regulatory responses between the prominent members of the TGF-b and JAK/STAT pathways and members of the FA core complex. Although the promoters are not well conserved, they share region and sequence specific regulatory motifs and transcription factor binding sites (TBFs), and we identified a bi-partite nature to these promoters. These results support a hypothesis based on the co-evolution of the FA core complex genes that was expanded to include their promoters.
In the context of this thesis, I investigated the molecular causes and functional consequences of genetic instability using a human inherited disease, Fanconi anemia. FA patients display a highly variable clinical phenotype, including congenital abnormalities, progressive bone marrow failure and a high cancer risk. The FA cellular phenotype is characterized by spontaneous and inducible chromosomal instability, and a typical S/G2 phase arrest after exposure to DNA-damaging agents. So far, 13 genes have been identified, whose biallelic (or, in the case of X-linked FANCB, hemizygous) mutations cause this multisystem disorder. The FA proteins interact in a multiprotein network, instrumental and essential in the cellular response to DNA damage. A more comprehensive summary of Fanconi anemia and its myriad clinical, cellular and molecular manifestations is provided in the introduction section of this thesis. The results of my experimental work are presented as published papers and manuscripts ready to be submitted. In the first publication, I investigated the connection between FA genes and bladder tumors. The question I tried to answer was whether a disruption of the FA/BRCA pathway may be a frequent and possibly causal event in bladder cancer, explaining the hypersensitivity of these cells to DNA-crosslinking agents. On the basis of my experimental data I arrived at the conclusion that disruption of the FA/BRCA pathway might be detrimental rather than advantageous for the majority tumor types by rendering them vulnerable towards DNA damaging agents and oxidative stress. The second publication deals with the gene coding for the core complex protein FANCE and tries to answer the question why FANCE is so rarely affected among FA-patients. The conclusion from these studies is that like FANCF, FANCE functions as a probable adaptor protein with a high tolerance towards amino acid substitutions which would explain the relative rareness of FA-E patients. I have also investigated the FANCL gene whose product functions as the catalytic subunit of the E3 ligase. The third publication addresses this issue by providing the first comprehensive description of genetic alterations and phenotypic manifestations in a series of three FA-L patients. The results of my study show that genetic alterations of FANCL are compatible with survival, these alterations may include large deletions such as so far common only in the FANCA gene, FA-L phenotypes can be mild to severe, and FANCL belongs to the group of FA genes that may undergo somatic reversion. The central protein of the FA/BRCA network, FANCD2, is the subject of the fourth publication presented in this thesis. Most importantly, we were able to show that there are no biallelic null mutations in FANCD2. Correspondingly, residual protein of both FANCD2-isotypes (FANCD2-S and FANCD2-L) was present in all available patient cell lines. This suggests that complete abrogation of the FANCD2 protein cannot be tolerated and causes early embryonic lethality. There are at least three FA proteins that are not required for the posttranslational modification of FANCD2. One of these proteins is the 5’-3’ helicase BRIP1 (BRCA1-interacting protein 1), a protein that interacts directly with the breast cancer susceptibility protein BRCA1. I participated in the identification of BRIP1 as the FA protein FANCJ. This discovery is described in the fifth publication of this thesis. The newly discovered protein BRIP1/FANCJ seems to act as one of the mediators of genomic maintenance downstream of FANCD2. Another protein identified downstream of FANCD2 is PALB2. PALB2 was originally discovered as “partner and localizer of BRCA2”. In a candidate gene approach we tested patients with early childhood cancers but without mutations in BRCA2 for mutations in PALB2 (publication 6). PALB2 was identified as a novel FA gene and designated FANCN. FA-N patients are very severely affected. The last publication included in my thesis describes the identification of the FA gene FANCI as the second monoubiquitinated member of the FA/BRCA pathway (publication 7). We identified biallelic mutations in KIAA1794 in four FA patients, thus proving the genuine FA-nature of this candidate sequence. The general discussion provides a synopsis of the results and conclusions of my work with the state of art of FA research.
Epimutations in Germ-Cell and Embryo Development: Possible Consequences for Assisted Reproduction
(2011)
Assisted reproductive technologies (ART) emerged in the late 1970’s as a therapy for human infertility. Up till now more than 3 million babies have been conceived through ART, demonstrating the safety and efficiency of the technique. Published reports showed an increase in the rate of imprinting disorders (Beckwith Wiedemann Syndrome, Angelman Syndrome, etc.) in babies born after ART. What are the effects imposed through ART and should researchers reassess its safety and implications on the future offspring? Throughout this thesis, I analyzed the methylation patterns of germ cells and embryos to determine whether in vitro maturation and in vitro fertilization have a negative impact on the epigenetic patterns. Furthermore, DNA methylation was compared between sperm of infertile and presumably fertile controls in order to understand whether epigenetic disturbances lead to infertility at the first place. The occurrence of methylation aberrations in germ cells of infertile patients could be transmitted to new-borns and then cause epigenetic disorders. In order to elucidate the imprinting status within single cells, I developed a new technique based on limiting dilution where bisulfite treated DNA is distributed across several wells before amplification. This allowed methylation measurement at the single allele level as well parent of origin detection. In a total of 141 sperm samples from couples undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) including 106 with male factor or combined infertility and 28 with female infertility, I detected a significant correlation between lower quality of semen parameters (sperm count, percentage of abnormal sperm, and percentage of motile sperm) and the rate of imprinting errors. ALU repeats displayed a higher methylation in sperm DNA of patients leading to a pregnancy and live birth, compared to patients in which pregnancy was not achieved or a spontaneous abortion occurred. A discriminant analysis based on ALU methylation allowed correct classification of >70% of cases. Preliminary data from illumina methylation arrays where more than 27,000 CpGs were analyzed determined that only a single CpG site from the open reading frame C14orf93 was significantly different between the infertile and presumably fertile control group. However, further improvements on data normalization might permit detection of other differentially methylated regions. Comparison of embryos after natural conception, in vitro fertilized embryos from superovulated oocytes, and embryos achieved through fertilization of in vitro cultured oocytes revealed no dramatic effect on the imprinting patterns of Igf2r, H19, and Snrpn. Oocyte cryotop vitrification did not result in a dramatic increase of imprinting mutations in oocytes even though the rate of sporadic methylation errors in single Snrpn CpGs were higher within the in-vitrified group. Collectively, the results I will present within this thesis suggest an increase in the rate of imprinting errors within the germ cells of infertile patients, in addition to a decrease in genome wide methylation of ALU repetitive elements. I did not observe a detrimental effect on the methylation patterns of oocytes and the resulting embryos using in vitro maturation of oocytes and/or standard IVF with in vivo grown superovulated oocytes.
Human caretaker genes play a central role in the DNA damage response. Their defects cause a number of rare diseases which show genetic instability and increased propensity to malignant cell growth. The first of these diseases to be described in this thesis is Fanconi anemia (FA), a rare chromosome instability disorder with recessive inheritance characterized by progressive bone marrow failure, variable congenital malformations, and cancer predisposition. There are at least 13 FA complementation groups (FA-A, B, C, D1, D2, E, F, G, I, J, L, M and N), each representing mutations in a distinct gene. To date, except FANCI all the corresponding genes have been identified, denoted as FANC-A, B, C, D1/BRCA2, D2, E, F, G, J/BRIP1/BACH1, L/PHF9, M/Hef and N/PALB2.Further information is provided in chapters 1 and 2. FA cells are characterized by high sensitivity to DNA crosslinking agents and to elevated oxygen tension, but it is controversial whether they are also radiosensitive. Systematic testing (chapter 3) of primary skin fibroblast cultures from all currently known FA complementation groups revealed no increased sensitivity towards ionizing radiation (IR) and ultra-violet light (UV) when growing cells at physiological (5% v/v) oxygen levels. Despite considerable interstrain variations FA cells showed no systematic differences to cell cultures derived from healthy controls, whereas positive controls (Ataxia telangiectasia and Cockayne syndrome) proved highly sensitive to IR or UV. Lack of radiosensitivity was also shown for the FANCD2 gene, a central gene in the FA/BRCA pathway whose mutational inactivation was studied in a large patient cohort. FA patients excluded previously from complementation groups FA-A, -C, E, F, G or L were screened for mutations in FANCD2. Even though mutation analysis of FANCD2 is complicated by the presence of pseudogene regions, biallelic FANCD2 mutations were identified in a series of 32 patients (chapter 4). The predominant types of mutations result in aberrant splicing causing exon skipping, exonisation of intronic sequence, activation of cryptic and creation of new 3´ splice sites. Many alleles were recurrent and could be associated with ethnicity. Interestingly, residual FANCD2 protein was observed in all available patient cell lines, and functionality was indicated by the presence of the monoubiquitinated FANCD2 isoform. This suggests that viability of FA-D2 patients depends on the presence of hypomorphic or leaky mutations. In chapter 5 the worldwide second FA patient belonging to complementation group FA-L is reported. Genetic analysis of patient derived fibroblasts revealed heterozygosity for a 5-bp deletion (exon 7) and a missense substitution (exon 11). In contrast to the tested fibroblasts two independent lymphoid cell lines proved resistant to the DNA crosslinking agent mitomycin C and showed proficient FANCD2 monoubiquitination. The functional reversion due to a compensating mutation in the splice acceptor site results in aberrant splicing and the restoration of the open reading frame. However, the revertant mosaicsm was restricted to the lymphatic cell lines such that there was no clinical improvement involving the other hematopoietic cell lineages, and bone marrow transplantation was required to treat the patients bone marrow failure. A direct link of Fanconi anemia to other DNA repair processes was provided by the identification of the BRCA1 interacting protein 1, BRIP1/BACH1, as a genuine FA gene (chapter 6). Genetic mapping of consanguineous Inuit families resulted in the identification of truncating mutations in BRIP1. In contrast to most of the other FA patients FANCD2 monoubiquitination was intact, linking these patients to complementation group FA-J. Biallelic mutations in BRIP1 were found in eight additional patients, one of whom was assigned previously to FA-J by somatic cell fusion. Therefore it could be shown that the postulated FANCJ gene is identical with BRIP1. This finding emphasizes the close connection between the BRCA- and the FA-family of genes, both involved in the DNA damage response. Biallelic mutations in BRCA2/FANCD1 cause a severe form of Fanconi anemia with childhood malignancies. Recently, a BRCA2 interacting protein was identified as a “partner and localizer of BRCA2” (PALB2) which confers cellular MMC resistance. A candidate gene approach revealed biallelic mutations in seven FA patients that developed solid tumors in early childhood (chapter 7). Patient cells show no or little PALB2 protein, lack of MMC induced RAD51 foci formation, and high chromosomal instability. Transduction of PALB2 cDNA complemented the MMC sensitive phenotype. Therefore, biallelic mutations in PALB2 cause a new subtype of FA, denoted as FA-N, which is connected with a high and early cancer risk. With respect to one of the most prominent but least understood caretaker gene syndromes, Fanconi anemia, this thesis has expanded our knowledge as follows: 1. refutation of major cellular radiosensitivity of FA cell lines regardless of complementation group, 2. detection of hypomorphic mutations and residual protein levels as a prerequisite for viability of the FANCD2 gene, 3. description of the worldwide second patient belonging to complementation group FA-L whose lymphocytes exhibit a novel type of somatic reversion, 4. participation in the discovery and functional characterization of two novel FA genes (FANCJ and FANCN). The last chapter of the thesis deals with a DNA repair pathway that is activated following exposure to ionizing radation. One of the central proteins responding to radiation-induced DNA damage is the product of the ATM gene which signals to a myriad of other proteins in response to DNA double strand breaks, including the NMR complex. This complex formed by the NBS1/MRE11/RAD50 proteins is thought to act as a specifi c sensor of DNA double-strand breaks. Mutations of MRE11 and NBS1 are associated with the radiation sensitivity syndromes Ataxia-telangiectasia-like disorder (AT-LD) and Nijmegen breakage syndrome (NBS), respectively. Chapter 8 presents the first ever identified patient with RAD50 deficiency due to biallelic germline mutations in the RAD50 gene. An 18-year-old German girl who has a variant form of NBS without immunodeficiency was found to be compound heterozygous for a nonsense mutation and the loss of the natural termination signal in the RAD50 gene. RAD50 protein expression was reduced to less than one tenth of normal in her fibroblasts and lymphoblastoid cells. At the nuclear level, RAD50 deficiency was associated with a high frequency of spontaneous chromatid exchanges and with the failure to form MRE11 and NBS1 nuclear foci in response to irradiation. ATM autophosphorylation, phosphorylation of p53 at serine 15 and the transcriptional induction of p21/WAF1 mRNA were reduced, and there was no evidence for Ser343 phosphorylation of NBS1 in RAD50 defi cient cells following irradiation. These defects could be complemented by expression of wildtype RAD50 cDNA. Our data shows that RAD50 modulates, like NBS1 and MRE11, the ATM-mediated DNA damage response and the G1/S cell cycle checkpoint. In addition, RAD50 appears to be required for nuclear localization of MRE11, and for NBS1 focus formation, underlining its importance for the proper function of the NMR complex. Owing to the studies performed within the framework of this thesis, RAD50 deficiency can now be added to the growing list of human caretaker gene syndromes with pronounced radiosensitivity that is distinctive at both the cellular and the clinical level from deficiencies involving the other members of the NMR complex.
Best disease, also termed vitelliform macular dystrophy type 2, VMD2, (OMIM #153700), is an autosomal dominant, early onset macular dystrophy associated with a remarkable accumulation of lipofuscin-like material within and beneath the retinal pigment epithelium (RPE). The VMD2 gene mutated in Best disease encodes a 585 amino acid putative transmembrane protein named bestrophin, and is preferentially expressed in the RPE. The protein has a complex membrane topology with 4-6 putative transmembrane domains (TMDs) and is presumably involved in Ca2+-dependent transport of chloride ions across the membrane. The vast majority of known disease-associated alterations are missense mutations nonrandomly distributed across the highly conserved N-terminal half of the protein with clusters near the predicted TMDs. The mechanism connecting Best disease pathology with the identified mutations or the Cl- channel function is not yet clear. To further elucidate the biological function of the bestrophin protein and to identify the molecular mechanisms underlying the disease, a search for interacting partners of bestrophin was performed using the GAL4-based yeast two hybrid system (Y2H). Screening of a bovine RPE cDNA library with various truncated bestrophin baits resulted in the identification of 53 putative interacting partners of bestrophin. However, verification of the interaction has excluded all candidate clones. Our comprehensive Y2H analyses suggest that bestrophin may not be suitable for traditional yeast two hybrid screens likely due to the fact that the protein is integral to the membrane and even fragments thereof may not be transported to the nucleus which is, however a prerequisite for protein interaction in the yeast system. Bestrophin belongs to a large family of integral membrane proteins with more than 100 members identified to date originating from evolutionarily diverse organisms such as mammals, insects and worms. The most distinctive feature of the bestrophin family, besides the invariant RFP (arginine-phenylalanine-proline) domain, is an evolutionarily highly conserved N-terminal region. To clarify the phylogenetic relationship among bestrophin homologues and to identify structural and functional motifs conserved across family members, a bioinformatics/phylogenetic study of the conserved N-terminal region was conducted. Phylogenetic analysis of the bestrophin homologues reveals existence of four evolutionary conserved family members in mammals, with high homology to the human VMD2, VMD2-L1 to L3 proteins. The significant level of protein sequence similarity between divergent species suggests that each of the bestrophin family members has a unique, Chapter One: Summary 2 evolutionarily conserved function and that the divergence of bestrophin into several family members occurred before the divergence of individual mammalian species.